Flag of Indiaसत्यमेव जयते AADTAK
GOOD BUSINESS DELHI-NCR

Biocon gets USFDA nod for breast cancer drug

New Delhi: Biopharmaceutical company Biocon Ltd on Monday said it has received approval from the US Food and Drug Administration (FDA) for Pebrilzo (pertuzumab-qcay) injection, a biosimilar to Perjeta, used in the treatment of HER2-positive

Economic Times Mon, 16 Nov 2026 08:09
Read the original at Economic Times ↗